Maky Zanganeh, Director at Pulse Biosciences, holds 610.02M shares in Summit Therapeutics (Ticker: SMMT), holds 873.47K shares in Pulse Biosciences (Ticker: PLSE), holds 0.00 shares in Pharmacyclics (Ticker: PCYC). Most recently, Maky Zanganeh Bought ― shares of Summit Therapeutics on Jun 12, 2026 for an estimated value of $49.99M.
What is the percentage of profitable transactions made by Maky Zanganeh?
The percentage of profitable transactions made by Maky Zanganeh is 60%.
What is the average return per transaction made by Maky Zanganeh?
The average return per transaction made by Maky Zanganeh is 83.50%.
What stocks does Maky Zanganeh hold?
Maky Zanganeh holds: PLSE, SMMT, PCYC stocks.
What was Maky Zanganeh’s latest transaction?
Maky Zanganeh latest transaction was an Informative Buy of $49.99M.
What was Maky Zanganeh's most profitable transaction?
Maky Zanganeh’s most profitable transaction was an Informative Buy of SMMT stock on December 13, 2023. The return on the trade was 661.90%.
What is Maky Zanganeh's role in Pulse Biosciences?
Maky Zanganeh's role in Pulse Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.